Join CRi, the newest educational sponsor on the Digital Pathology Blog for a webinar on a new imaging tool.  These technologies are important because unlike light microscopy where single or double immunostains or IF stains performed and reviewed manualy typically look at tumor biology, digital imaging technologies allow us to study cell(ular) biology with much greater sensitivity and specificity than conventional microscopy.  These technologies provide a slide-based surrogate for molecular analysis by being able to look at multiple antibodies or markers simultaneously in individual cells rather than single stains on a single tumor section.

Learn how a new imaging tool developed by CRi can enable you to explore new molecular combinations in a single tissue section, expanding what’s possible in biomarker discovery, oncology translational research, and molecular epidemiology. Define how many cells are double-negative, single-positive for one label, single-positive for another label, or double-positive from your immunohistochemical or immunofluorescence tissue sample. ??You can now start asking more demanding scientific questions, such as how many tumor cells are proliferating, what is the normalized phosphor-EGFR expression, how many cancer stem cells are present, or how many cells have had a phospho-epitope travel across the nuclear membrane. New commercially-available multilabel antibody kits will also be discussed

Title:

New Double-Positivity Tool for MultiColor IHC and IF

Date:

Thursday, August 26, 2010

Time:

1:00 PM - 2:00 PM EDT

After registering you will receive a confirmation email containing information about joining the Webinar.

System Requirements? - PC-based attendees? - Required: Windows® 7, Vista, XP, 2003 Server or 2000

Macintosh®-based attendees? - Required: Mac OS® X 10.4.11 (Tiger®) or newer

Space is limited.?Reserve your Webinar seat now at:

https://www1.gotomeeting.com/register/557136369